Balloon sinuplasty: our first year

Hopkins, Claire; Noon, Edward; Bray, Dominic; Roberts, David

doi:10.1017/s0022215110001520

Cited by 18 publications

(22 citation statements)

References 12 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results prove the safety and feasibility of this surgical procedure yet established in previous studies [13,21,22,23,24,25]. However we demonstrate the safety and efficacy of this technique also in onco-hematological patients with sinus dysfunction.…”

Section: Discussionsupporting

confidence: 86%

Surgical Management of Rhinosinusitis in Onco-Hematological Patients

Girolamo

Mazzone

Mauro

et al. 2014

Clin Exp Otorhinolaryngol

View full text Add to dashboard Cite

ObjectivesIn onco-hematological diseases, the incidence of paranasal sinuses infection dramatically increase and requires a combination of medical and surgical therapy. Balloon dilatation surgery (DS) is a minimally invasive, tissue preserving procedure. The study evaluates the results of DS for rhinosinusitis in immunocompromised patients.MethodsA retrospective chart review was conducted in 110 hematologic patients with rhinosinusitis. Twenty-five patients were treated with DS technique and 85 patients with endoscopic sinus surgery (ESS). We considered the type of anesthesia and the extent of intra- and postoperative bleeding. Patients underwent Sino-Nasal Outcome Test (SNOT-20) to evaluate changes in subjective symptoms and global patient assessment (GPA) questionnaire to value patient satisfaction.ResultsLocal anesthesia was employed in 8 cases of DS and in 15 of ESS. In 50 ESS patients, an anterior nasal packing was placed and in 12 cases a repacking was necessary. In the DS group, nasal packing was required in 8 cases and in 2 cases a repacking was placed (P=0.019 and P=0.422, respectively). The SNOT-20 change score showed significant improvement of health status in both groups. However the DS group showed a major improvement in 3 voices: need to blow nose, runny nose, and facial pain/pressure. The 3-month follow-up GPA questionnaire showed an higher satisfaction of DS group.ConclusionBalloon DS represents a potentially low aggressive treatment and appears to be relatively safe and effective in onco-hematologic patients. All these remarks may lead the surgeon to consider a larger number of candidates for surgical procedure.

show abstract

Section: Discussionsupporting

confidence: 86%

Surgical Management of Rhinosinusitis in Onco-Hematological Patients

Girolamo

Mazzone

Mauro

et al. 2014

Clin Exp Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…Full‐length texts were then reviewed, and an additional 23 studies identified from references. A total of 31 studies were considered to be duplicates from the same cohort, and an additional 53 failed to meet inclusion/exclusion criteria. The final study list included 40 unique patient cohorts published from 2008 to 2016 and representing institutions from North America (n = 14), Europe (n = 12), Middle East (n = 6), Australia (n = 3), Asia (n = 3), and South America (n = 2) .…”

Section: Resultsmentioning

confidence: 99%

Sino‐Nasal outcome test‐22 outcomes after sinus surgery: A systematic review and meta‐analysis

Soler

Jones

et al. 2017

The Laryngoscope

View full text Add to dashboard Cite

show abstract

“…Hopkins et al . describing the results of balloon sinuplasty in 27 patients (67 sinuses) report no feasibility problems with successful dilatation achieved in 98% of sinuses . Raghunandhan et al .…”

Section: Discussionmentioning

confidence: 97%